Synthetic composition for treating metabolic disorders
US10881674B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2016 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Jun 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method for stabilising or reducing insulin resistance in patients having an obesity-related, metabolic disorder, the method comprising administering to the patient an effective amount of one or more human milk oligosaccharides (HMOs).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.